ExpressionEdits

ExpressionEdits: AI-driven transgene redesign to unlock protein expression for therapeutic applications. BioTech · Seed · Haverhill, United Kingdom. Rated…

AI-driven transgene redesign to unlock protein expression for therapeutic applications.

Preliminary profile · public data only

Startup24 listed ExpressionEdits from public information on the company's own website; its founders have not claimed or verified the profile yet. The rating below is preliminary, based on public data only, and is an opinion — not investment advice. Founders can claim the profile, and anyone can report an error or request removal, on this page.

At a glance

• Category: BioTech (Gene expression engineering and therapeutic proteins)
• Stage: Seed
• Location: Haverhill, United Kingdom

Startup24 rating: 71/100

ExpressionEdits is a seed-stage biotech with a focused transgene-redesign platform addressing a meaningful expression bottleneck and a potentially useful compact-intronization approach.

About the rating

Every startup on Startup24 is scored on the same six criteria — team, market, product, advantages, risk and reputation — with the reasoning written out. Founders list for free; investors subscribe to see the full analysis.

• How the score is calculated
• Browse the catalogue

Startup24 (startup-24.com) rates startups on real, verified data: founders list for free, investors subscribe to find them first. Operated by DOTOVO OÜ, Tallinn, Estonia.